Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgery and Intracavitary Photodynamic Therapy (PDT) for the Treatment of Malignant Pleural Mesothelioma
NCT00054002Phase 2Completed
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- Mar 1999
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of porfimer sodium in malignant mesothelioma, sponsored by Roswell Park Comprehensive Cancer Center. Primary endpoints: Feasibility, Comparison of results from this regimen to historical controls and 1 more. Started Mar 1999; status: completed.
02
Drugs
porfimer sodium
03
Conditions
malignant mesothelioma
Beyond the preview
Go deeper on NCT00054002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00054002.